Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease-Reference-Cited by-同舟云学术

Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease

Published:2022-01 Issue:1 Volume:30 Page:145-163
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Ramadier Sophie,Chalumeau Anne,Felix Tristan,Othman Nadia,Aknoun Sherazade,Casini Antonio,Maule Giulia,Masson Cecile,De Cian Anne,Frati Giacomo,Brusson Megane,Concordet Jean-Paul,Cavazzana Marina,Cereseto Anna,El Nemer Wassim,Amendola Mario,Wattellier Benoit,Meneghini Vasco,Miccio Annarita

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference80 articles.

1. Gene therapy for β-hemoglobinopathies;Cavazzana;Mol. Ther.,2017

2. Causes of death in sickle cell disease adult patients: Old and new trends;Ngo;Blood,2014

3. Therapeutic options for patients with severe β-thalassemia: The need for globin gene therapy;Sadelain;Hum. Gene Ther.,2007

4. On modeling human leukocyte antigen-identical sibling match probability for allogeneic hematopoietic cell transplantation: Estimating the need for an unrelated donor source;Besse;Biol. Blood Marrow Transplant.,2016

5. In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of β-thalassemia;Miccio;Proc. Natl. Acad. Sci. USA,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR technology in human diseases;MedComm;2024-07-29

2. EDIÇÃO GENÔMICA: UMA NOVA ESPERANÇA NO TRATAMENTO DA DOENÇA FALCIFORME?;RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218;2024-06-05

3. Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats–Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency and Optimization Strategies;Human Gene Therapy;2023-12-01

4. Combined approaches for increasing fetal hemoglobin (HbF) and de novo production of adult hemoglobin (HbA) in erythroid cells from β-thalassemia patients: treatment with HbF inducers and CRISPR-Cas9 based genome editing;Frontiers in Genome Editing;2023-07-17

5. Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies;Molecular Therapy - Nucleic Acids;2023-06